HC Wainwright restated their buy rating on shares of Enlivex Therapeutics (NASDAQ:ENLV – Free Report) in a report released on Tuesday, Benzinga reports. The firm currently has a $7.00 target price on the stock. Enlivex Therapeutics Trading Down 3.3 % Shares of ENLV stock opened at $1.45 on Tuesday. Enlivex Therapeutics has a 52-week low […]